Portfolio

We invest in the technologies of tomorrow.

Esco Ventures invests in life science startups and is also engaged in venture creation to discover and develop technologies addressing large unmet medical needs. Our companies are collaborating with leading academic institutions, hospitals and clinicians around the world to discover and develop these technologies.

AT Medical Ltd. develops, manufactures and sells state-of-the-art IVF medical device technology

AT Medical Ltd.

Strategic Investment

* Acquired by Esco Medical

Carmentix

Carmentix is an Esco Ventures X founded startup company developing a novel biomarker prognostic panel for preterm birth. Carmentix is determined to significantly reduce the number of preterm birth in the global setting by establishing biomolecular tools that will alert clinicians for the risk of preterm birth weeks before symptoms occur.

Venture Creation

Carmine Therapeutics

Venture Creation

Carmine Therapeutics is an Esco Ventures X company pioneering a powerful new class of drugs based on engineered red blood cells extracellular vesicles (RBCEVs), founded by Esco Ventures and Professors Harvey Lodish, Minh Le and Jiahai Shi.

Hummingbird Bioscience

Venture Investment

Hummingbird Bioscience focuses on the discovery and early development of oncology drugs, from pre-clinical target validation to proof-of-concept (Phase II Clinical Trials).

Javelin Medical

Javelin Medical is developing a permanent carotid implant for stroke prevention in atrial fibrillation patients, which can be placed bedside within seconds under ultrasound guidance

Venture Investment

Medical Plast

Medical Plast develops and manufactures proprietary high value medical consumables and reagents.

Strategic Investment

* Acquired by Esco Medical

NanoView Biosciences

Using innovative and proprietary technology, Nanoview Biosciences is striving to become the leader in exosomes analysis for basic research, therapeutics development and medical diagnostics

Venture Investment